Harvoni hepatitis C drug

Harvoni hepatitis C drug

C024/6084 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 55.0MB

Downloadable file size: 2.5MB

Price image Pricing

Please login to use the price calculator


Credit: GEORGE POST/SCIENCE PHOTO LIBRARY

Caption: Harvoni hepatitis C drug. Pills for the combination drug Harvoni, used to treat chronic hepatitis C infections. It contains the drugs sofosbuvir and ledipasvir. Sofosbuvir is an antiviral drug that works by inhibiting the enzyme that the virus uses to replicate its RNA (ribonucleic acid) genome. Ledipasvir is an antiviral protease inhibitor drug that inhibits the action of a protein that is vital for RNA replication. The hepatitis C virus infects liver cells causing an inflammatory disease that can lead to degeneration and scarring (cirrhosis). Harvoni cures 90 per cent of patients. Produced by Gilead Sciences, this drug was first approved for use in October 2014.

Release details: Model release not required. Property release not required.

Keywords: 2, 2014, 2015, 21st century, 7985, anti-hepatitis, antiviral, biochemical, caplet, caplets, drug, duo, enzyme inhibitor, gilead sciences, gsi, harvoni, hcv, hepatitis c, illustration, inhibitor, ledipasvir, liver disease, medical, medicine, no-one, nobody, pair, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pill, pills, prescription drug, protease inhibitor, rna polymerase inhibitor, sofosbuvir, still life, still-life, studio shot, tablet, tablets, treatment, two, white background

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.